News
Merck and Baylor College of Medicine collaborate to advance COVID-19 vaccine manufacturing platform
The Merck-Baylor teams will improve the manufacturing platform for the CoV RBD219-N1 vaccine candidate, which was originally developed to target SARS in 2011-2016.
